Delivery Order SPE2DB22D3004-SPE2DB25FPM69
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 400 mg/200 mL vials of Ropivacaine 0.2%, a local anesthetic medication. The contract has a ceiling value of $2,665.10 and is a firm fixed-price delivery order that runs through January 2025. The contract is not designated as a set-aside. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $14,089.80, is for the delivery of 400 mg/200 mL Ropivacaine 0.2% injectable medication. The contract is structured as a Firm Fixed Price Delivery Order with an ultimate completion date of November 16, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,951.54, is for the delivery of 4563417403 ropivacaine 0.2% 200 mg/100 ml medication. The contract is a firm fixed-price Delivery Order with a completion date of January 25, 2024. The contract was not set aside and is part of AmerisourceBergen's larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,731.07, is for the supply of 400 mg/200 mL ropivacaine 0.2% injectable medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 400 mg/200 ml vials of the anesthetic medication Ropivacaine 0.2%, with a ceiling value of $1,816.72 and a completion date of February 14, 2024. The contract is a firm fixed-price Indefinite Delivery Contract vehicle, with no set-aside designation, that allows the DLA to procure a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA) for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectables. The contract, valued at $3,324.51, is a firm fixed-price delivery order with a period of performance through January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 ml ropivacaine (a pain medication) at a ceiling value of $1,823.16. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a broad range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5% ropivacaine 150 mg/30 ml (30 ml) at a ceiling value of $2,104.56. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 milliliter vials of 0.2% Ropivacaine, a local anesthetic medication. The award, valued at $1,235.57, is a Firm Fixed Price delivery order contract with a completion date of December 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication, valued at $6,539.27, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which supplies a comprehensive range of pharmaceutical products and medical supplies to...